litlas
Log inCreate account

Qi Xue

Active 2002–2026

230
Papers
20,262
Citations
54
h-index
187
i10-index

Citations

Citations per year for Qi Xue1971: 1 citations1992: 1 citations2002: 1 citations2003: 9 citations2004: 33 citations2005: 88 citations2006: 78 citations2007: 72 citations2008: 97 citations2009: 95 citations2010: 78 citations2011: 74 citations2012: 80 citations2013: 59 citations2014: 66 citations2015: 64 citations2016: 81 citations2017: 154 citations2018: 265 citations2019: 367 citations2020: 478 citations2021: 557 citations2022: 544 citations2023: 497 citations2024: 767 citations2025: 502 citations2026: 22 citations1972–1991: no citations, so these years are not shown1993–2001: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,563 citing papers, 36.3% of this breakdownUnited States: 1,303 citing papers, 18.5% of this breakdownUnited Kingdom: 215 citing papers, 3.1% of this breakdownIndia: 182 citing papers, 2.6% of this breakdownJapan: 177 citing papers, 2.5% of this breakdownAustralia: 169 citing papers, 2.4% of this breakdownSouth Korea: 164 citing papers, 2.3% of this breakdownItaly: 157 citing papers, 2.2% of this breakdownCanada: 155 citing papers, 2.2% of this breakdownHong Kong: 155 citing papers, 2.2% of this breakdownGermany: 135 citing papers, 1.9% of this breakdownSpain: 127 citing papers, 1.8% of this breakdown
0%36.3%Other 22%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology27.9%
  • Medicine27.3%
  • Materials Science13.2%
  • Engineering10%
  • Computer Science8.3%
  • Psychology3.4%
  • Other9.9%

Topics

  • Cancer Immunotherapy and Biomarkers3.2%
  • MXene and MAX Phase Materials2.8%
  • RNA modifications and cancer2.7%
  • Advanced biosensing and bioanalysis techniques2.1%
  • Supercapacitor Materials and Fabrication2%
  • Mobile Ad Hoc Networks1.9%
  • Other85.3%

Coauthors

All papers

Open in search
  1. Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis

    Authors: Xiaoxiang Zhou, Zhuoran Yao, Hua Bai, Jianchun Duan, Zhijie Wang, Xin Wang, Xue Zhang, Jiachen Xu, Kailun Fei, Zhen Zhang, Fengwei Tan, Qi Xue, Shugeng Gao, Yibo Gao, Jie Wang, Jie He - The Lancet Oncology 2021 cited by 242

  2. Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC

    Authors: Bin Qiu, Wei Guo, Fan Zhang, Fang Lv, Ying Ji, Yue Peng, Xiaoxi Chen, Hua Bao, Yang Xu, Yang Shao, Fengwei Tan, Qi Xue, Shugeng Gao, Jie He - Nature Communications 2021 cited by 285

  3. KRAS ‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer

    Authors: Chengming Liu, Sufei Zheng, Zhanyu Wang, Sihui Wang, Xin‐Feng Wang, Lu Yang, Haiyan Xu, Zheng Cao, Xiaoli Feng, Qi Xue, Yan Wang, Nan Sun, Jie He - Cancer Communications 2022 cited by 175

  4. Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC

    Authors: Shugeng Gao, Ning Li, Shun‐Yu Gao, Qi Xue, Jianming Ying, Shuhang Wang, Xiuli Tao, Jun Zhao, Yousheng Mao, Bing Wang, Kang Shao, Wendong Lei, Dali Wang, Fang Lv, Liang Zhao, Fan Zhang, Ziran Zhao, Kai Su, Fengwei Tan, Yibo Gao, Nan Sun, Dawei Wu, Yue Yu, Yun Ling, Zhijie Wang, Chunjian Duan, Wei Tang, Lei Zhang, Shun He, Ning Wu, Jie Wang, Jie He - Journal of Thoracic Oncology 2020 cited by 415

  5. Photoluminescent Ti3C2 MXene Quantum Dots for Multicolor Cellular Imaging

    Authors: Qi Xue, Huijie Zhang, Minshen Zhu, Zengxia Pei, Hongfei Li, Zifeng Wang, Yang Huang, Yan Huang, Qihuang Deng, Jie Zhou, Shiyu Du, Qing Huang, Chunyi Zhi - Advanced Materials 2017 cited by 953

  6. Meta‐analysis: global prevalence, trend and forecasting of non‐alcoholic fatty liver disease in children and adolescents, 2000–2021

    Authors: Jie Li, Audrey Ha, Fajuan Rui, Biyao Zou, Hongli Yang, Qi Xue, Xinyu Hu, Yayun Xu, Linda Henry, Monique T. Barakat, Christopher D Stave, Junping Shi, Chao Wu, Ramsey Cheung, Mindie H. Nguyen - Alimentary Pharmacology & Therapeutics 2022 cited by 112

  7. METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding

    Authors: Wei Wang, Fei Shao, Xueying Yang, Juhong Wang, Rongxuan Zhu, Yannan Yang, Gaoxiang Zhao, Dong Guo, Yingli Sun, Jie Wang, Qi Xue, Shugeng Gao, Yibo Gao, Jie He, Zhimin Lu - Nature Communications 2021 cited by 193

  8. Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma

    Authors: Wei Guo, Bolun Zhou, Zhenlin Yang, Xiang Liu, Qilin Huai, Lei Guo, Xuemin Xue, Fengwei Tan, Yin Li, Qi Xue, Shugeng Gao, Jie He - EBioMedicine 2022 cited by 78

  9. Genetic landscape of esophageal squamous cell carcinoma

    Authors: Yibo Gao, Zhao-Li Chen, Jia-Gen Li, Xue-Da Hu, Xue-Jiao Shi, Zeng-Miao Sun, Fan Zhang, Zi-Ran Zhao, Zi-Tong Li, Zi-Yuan Liu, Yu-Da Zhao, Jian Sun, Cheng-Cheng Zhou, Ran Yao, Su-Ya Wang, Pan Wang, Nan Sun, Bai-Hua Zhang, Jing-Si Dong, Yue Yu, Mei Luo, Xiao-Li Feng, Su-Sheng Shi, Fang Zhou, Feng-Wei Tan, Bin Qiu, Ning Li, Kang Shao, Li-Jian Zhang, Lan-Jun Zhang, Qi Xue, Shu-Geng Gao, Jie He - Nature Genetics 2014 cited by 719

  10. Smart Nanosensitizers for Activatable Sono‐Photodynamic Immunotherapy of Tumors by Redox‐Controlled Disassembly

    Authors: Lingjun Liu, Junya Zhang, Ruibing An, Qi Xue, Xi Cheng, Yuxuan Hu, Zheng Huang, Luyan Wu, Wenhui Zeng, Yinxing Miao, Jie Li, Yu Zhou, Hong‐Yuan Chen, Hong Liu, Deju Ye - Angewandte Chemie 2023 cited by 75

  11. Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection

    Authors: Hua Bao, Zheng Wang, Xiaoji Ma, Wei Guo, Xiangyu Zhang, Wanxiangfu Tang, Xin Chen, Xinyu Wang, Yikuan Chen, Shaobo Mo, Naixin Liang, Qianli Ma, Shuyu Wu, Xiuxiu Xu, Shuang Chang, Yu‐Lin Wei, Xian Zhang, Hairong Bao, Rui Liu, S Samuel Yang, Ya Jiang, Xue Wu, Yaqi Li, Long Zhang, Fengwei Tan, Qi Xue, Fangqi Liu, Sanjun Cai, Shugeng Gao, Junjie Peng, Jian Zhou, Yang Shao - Molecular Cancer 2022 cited by 88

  12. A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments

    Authors: Yanmei Zhang, Qifan Hu, Yuquan Pei, Hao Luo, Zixuan Wang, Xinxin Xu, Qing Zhang, Jianli Dai, Qianqian Wang, Zilian Fan, Yongcong Fang, Min Ye, Binhan Li, Mailin Chen, Qi Xue, Qingfeng Zheng, Shulin Zhang, Miao Huang, Ting Zhang, Jin Gu, Zhuo Xiong - Nature Communications 2024 cited by 72

  13. Antigen-Specific T Cell Detection via Photocatalytic Proximity Cell Labeling (PhoXCELL)

    Authors: Hongyu Liu, Huixin Luo, Qi Xue, Shan Qin, Shuang Qiu, Shibo Liu, Jian Lin, Jie Li, Peng R. Chen - Journal of the American Chemical Society 2022 cited by 79

  14. Combining cisplatin and a STING agonist into one molecule for metalloimmunotherapy of cancer

    Authors: Shuren Zhang, Dongfan Song, Wenhao Yu, Ji Li, Xiaoyu Wang, Yachao Li, Zihan Zhao, Qi Xue, Jing Zhao, Jie Li, Zijian Guo, Jie Li, Zijian Guo - National Science Review 2023 cited by 47

  15. Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling

    Authors: Wei Guo, Xin Chen, Rui Liu, Naixin Liang, Qianli Ma, Hua Bao, Xiuxiu Xu, Xue Wu, S Samuel Yang, Yang Shao, Fengwei Tan, Qi Xue, Shugeng Gao, Jie He - EBioMedicine 2022 cited by 75

  16. Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With Resectable NSCLC: A Phase 2 Clinical Trial

    Authors: Jun Zhao, Liang Zhao, Wei Guo, Shuhang Wang, Xiuli Tao, Lin Li, Yousheng Mao, Fengwei Tan, Yushun Gao, Ning Wu, Jianming Ying, Qi Xue, Ning Li, Shugeng Gao, Jié He - Journal of Thoracic Oncology 2023 cited by 54

  17. Pyrroloquinoline quinone alleviates natural aging‐related osteoporosis via a novel MCM3‐Keap1‐Nrf2 axis‐mediated stress response and Fbn1 upregulation

    Authors: Jie Li, Jing Zhang, Qi Xue, Boyang Liu, Ran Qin, Yiping Li, Yue Qiu, Rong Wang, David Goltzman, Dengshun Miao, Renlei Yang - Aging Cell 2023 cited by 32

  18. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

    Authors: Pradip K. Majumder, Phillip G. Febbo, Rachel Bikoff, Raanan Berger, Qi Xue, Louis McMahon, Judith Manola, James Brugarolas, Timothy J. McDonnell, Todd R. Golub, Massimo Loda, Heidi A. Lane, William R. Sellers - Nature Medicine 2004 cited by 956

  19. Blocking P2X7-Mediated Macrophage Polarization Overcomes Treatment Resistance in Lung Cancer

    Authors: Juliang Qin, Xiaoyu Zhang, Binghe Tan, Su Zhang, Chengcong Yin, Qi Xue, Zhen Zhang, Hua Ren, Jinlian Chen, Mingyao Liu, Min Qian, Bing Du - Cancer Immunology Research 2020 cited by 82

  20. Efficient Nitrate-to-Ammonia Electroreduction at Cobalt Phosphide Nanoshuttles

    Authors: Yi Jia, Yi‐Gang Ji, Qi Xue, Fumin Li, Guangtao Zhao, Pujun Jin, Shu-Ni Li, Yu Chen - ACS Applied Materials & Interfaces 2021 cited by 69

  21. Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis

    Authors: Yu Jun Wong, Vy H. Nguyen, Hwai‐I Yang, Jie Li, Michael H. Le, Wan‐Jung Wu, Nicole Xinrong Han, Khi Yung Fong, Elizebeth Chen, Connie Wong, Fajuan Rui, Xiaoming Xu, Qi Xue, Xin Hu, Wei Qiang Leow, George Boon‐Bee Goh, Ramsey Cheung, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, Ming‐Whei Yu, Mindie H. Nguyen - Clinical and Molecular Hepatology 2023 cited by 67

  22. High-Precision Intelligent Cancer Diagnosis Method: 2D Raman Figures Combined with Deep Learning

    Authors: Yafeng Qi, Guochao Zhang, Lin Yang, Bangxu Liu, Hui Zeng, Qi Xue, Dameng Liu, Qingfeng Zheng, Yuhong Liu - Analytical Chemistry 2022 cited by 47

  23. Ultrathin MXene‐Micropattern‐Based Field‐Effect Transistor for Probing Neural Activity

    Authors: Bingzhe Xu, Minshen Zhu, Wencong Zhang, Xu Zhen, Zengxia Pei, Qi Xue, Chunyi Zhi, Peng Shi - Advanced Materials 2016 cited by 587

  24. Induction Immune Checkpoint Inhibitors and Chemotherapy Before Definitive Chemoradiation Therapy for Patients With Bulky Unresectable Stage III Non-Small Cell Lung Cancer

    Authors: Yu Wang, Tao Zhang, Jianyang Wang, Zongmei Zhou, Wenyang Liu, Zefen Xiao, Lei Deng, Qinfu Feng, Xin Wang, Jima Lv, Xiangyu Ma, Qi Xue, Jie Wang, Zhijie Wang, Nan Bi - International Journal of Radiation Oncology*Biology*Physics 2023 cited by 53